Page 5 - Chief Technical Operations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Industry News: Moderna announces agreement with Thermo Fisher Scientific for manufacturing of Moderna’s COVID-19 vaccine Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines 04 Jun 2021 Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine. Under the terms of the agreement, Thermo Fisher’s commercial manufacturing site in Green...

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands - read this article along with other careers information, tips and advice on BioSpace

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 3, 2021 /PRNewswire/ -- As the world has adapted to the initial phase of the global pandemic, and vaccines are being manufactured

Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an agreement with Thermo Fisher Scie...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 2, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an additional agreement with Lonza (SIX: LONN) to support drug substance manufacturing for its global supply chain. The agreement will establish a new production line at Lonza’s Geleen site in the Netherlands, contributing to the supply of an additional 300 million doses of Moderna’s updated booster variant vaccine candidate, if authorized, per year, at a 50 µg dose. In addition t...